Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Corcept Therapeutics Inc.

Begin the MOMENTUM clinical trial

Delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
26 Feb 2025
Due
31 Mar 2025
Delivered
March 2025
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“MOMENTUM – 1,000-patient trial examining the prevalence of hypercortisolism in patients with resistant hypertension to begin this quarter”

What we found

Evidence strength A What the grades mean

The company initiated the MOMENTUM clinical trial in March 2025, which falls within the first quarter of 2025.

  • A
    Corcept Therapeutics Inc. 10-Q filed 2025-05-05 Regulatory filing · published 5 May 2025 · retrieved 1 Oct 2026 · kept permanently by the SEC · fingerprint 53f61cf7bada
    “In March 2025, we initiated the “MOMENTUM” trial to establish the prevalence of endogenous hypercortisolism in patients with resistant hypertension.” ✓ confirmed on the page

Market reaction: the shares moved -2.2% against the S&P 500 over the three sessions around the disclosure (2 May 2025 to 7 May 2025). What this measures

Checked 1 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical milestone
Indicative materiality
Medium rules
Action
Begin
Deliverable
MOMENTUM clinical trial
Target
1,000 patients
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Corcept Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2025-CORT-002909 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.